UniProt ID | CERS5_HUMAN | |
---|---|---|
UniProt AC | Q8N5B7 | |
Protein Name | Ceramide synthase 5 | |
Gene Name | CERS5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 392 | |
Subcellular Localization |
Nucleus membrane Multi-pass membrane protein . Endoplasmic reticulum membrane Multi-pass membrane protein. |
|
Protein Description | Dihydroceramide synthase. Catalyzes the acylation of sphingosine to form dihydroceramide, with high selectivity toward palmitoyl-CoA as acyl donor compared to stearoyl-CoA. Inhibited by fumonisin B1 (By similarity).. | |
Protein Sequence | MATAAQGPLSLLWGWLWSERFWLPENVSWADLEGPADGYGYPRGRHILSVFPLAAGIFFVRLLFERFIAKPCALCIGIEDSGPYQAQPNAILEKVFISITKYPDKKRLEGLSKQLDWNVRKIQCWFRHRRNQDKPPTLTKFCESMWRFTFYLCIFCYGIRFLWSSPWFWDIRQCWHNYPFQPLSSGLYHYYIMELAFYWSLMFSQFTDIKRKDFLIMFVHHLVTIGLISFSYINNMVRVGTLIMCLHDVSDFLLEAAKLANYAKYQRLCDTLFVIFSAVFMVTRLGIYPFWILNTTLFESWEIIGPYASWWLLNGLLLTLQLLHVIWSYLIARIALKALIRGKVSKDDRSDVESSSEEEDVTTCTKSPCDSSSSNGANRVNGHMGGSYWAEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | N-linked_Glycosylation | ERFWLPENVSWADLE CCCCCCCCCCHHHCC | 31.05 | 29632068 | |
55 | Ubiquitination | LSVFPLAAGIFFVRL HHHHHHHHHHHHHHH | 21.21 | 21890473 | |
55 | Ubiquitination | LSVFPLAAGIFFVRL HHHHHHHHHHHHHHH | 21.21 | 21890473 | |
63 | Ubiquitination | GIFFVRLLFERFIAK HHHHHHHHHHHHCCC | 2.69 | - | |
98 | Phosphorylation | ILEKVFISITKYPDK HHHHHHHHHHCCCCH | 16.85 | 24719451 | |
113 | Ubiquitination | KRLEGLSKQLDWNVR HHHHHHHHHCCHHHH | 60.98 | 21890473 | |
120 | Ubiquitination | KQLDWNVRKIQCWFR HHCCHHHHHHHHHHH | 27.44 | 27667366 | |
121 | Malonylation | QLDWNVRKIQCWFRH HCCHHHHHHHHHHHH | 32.61 | 26320211 | |
121 | Ubiquitination | QLDWNVRKIQCWFRH HCCHHHHHHHHHHHH | 32.61 | - | |
134 | Acetylation | RHRRNQDKPPTLTKF HHCCCCCCCCCHHHH | 43.03 | 19817403 | |
199 | Ubiquitination | IMELAFYWSLMFSQF HHHHHHHHHHHHHHH | 4.41 | 32015554 | |
206 | Ubiquitination | WSLMFSQFTDIKRKD HHHHHHHHCCCCCHH | 6.85 | 27667366 | |
264 | Ubiquitination | AKLANYAKYQRLCDT HHHHCHHHHHHHHHH | 31.40 | 27667366 | |
345 | Phosphorylation | ALIRGKVSKDDRSDV HHHCCCCCCCCHHHC | 33.58 | 30108239 | |
350 | Phosphorylation | KVSKDDRSDVESSSE CCCCCCHHHCCCCCC | 53.67 | 21082442 | |
354 | Phosphorylation | DDRSDVESSSEEEDV CCHHHCCCCCCCCCC | 38.73 | 25159151 | |
355 | Phosphorylation | DRSDVESSSEEEDVT CHHHCCCCCCCCCCC | 28.41 | 21082442 | |
356 | Phosphorylation | RSDVESSSEEEDVTT HHHCCCCCCCCCCCC | 59.30 | 21082442 | |
362 | Phosphorylation | SSEEEDVTTCTKSPC CCCCCCCCCCCCCCC | 28.60 | 20873877 | |
363 | Phosphorylation | SEEEDVTTCTKSPCD CCCCCCCCCCCCCCC | 20.30 | 20873877 | |
365 | Phosphorylation | EEDVTTCTKSPCDSS CCCCCCCCCCCCCCC | 32.25 | 20873877 | |
367 | Phosphorylation | DVTTCTKSPCDSSSS CCCCCCCCCCCCCCC | 16.77 | 21815630 | |
388 | Phosphorylation | NGHMGGSYWAEE--- CCCCCCCCCCCC--- | 16.35 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
350 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
354 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
355 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
356 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CERS5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CERS5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of CERS5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-354; SER-355AND SER-356, AND MASS SPECTROMETRY. |